ipharmacy direct ltd Company Information
Company Number
08314332
Next Accounts
Aug 2025
Industry
Dispensing chemist in specialised stores
Directors
Shareholders
salma shakoor
shain nawaz
View AllGroup Structure
View All
Contact
Registered Address
2 raynham street, ashton-under-lyne, OL6 9NU
Website
www.ipharmacydirect.co.ukipharmacy direct ltd Estimated Valuation
Pomanda estimates the enterprise value of IPHARMACY DIRECT LTD at £285.3k based on a Turnover of £911.8k and 0.31x industry multiple (adjusted for size and gross margin).
ipharmacy direct ltd Estimated Valuation
Pomanda estimates the enterprise value of IPHARMACY DIRECT LTD at £230.6k based on an EBITDA of £63k and a 3.66x industry multiple (adjusted for size and gross margin).
ipharmacy direct ltd Estimated Valuation
Pomanda estimates the enterprise value of IPHARMACY DIRECT LTD at £322.5k based on Net Assets of £151.2k and 2.13x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Ipharmacy Direct Ltd Overview
Ipharmacy Direct Ltd is a live company located in ashton-under-lyne, OL6 9NU with a Companies House number of 08314332. It operates in the dispensing chemist in specialised stores sector, SIC Code 47730. Founded in November 2012, it's largest shareholder is salma shakoor with a 25% stake. Ipharmacy Direct Ltd is a established, small sized company, Pomanda has estimated its turnover at £911.8k with high growth in recent years.
Upgrade for unlimited company reports & a free credit check
Ipharmacy Direct Ltd Health Check
Pomanda's financial health check has awarded Ipharmacy Direct Ltd a 5 rating. We use a traffic light system to show it exceeds the industry average on 5 measures and has 3 areas for improvement. Company Health Check FAQs
5 Strong
3 Regular
3 Weak
Size
annual sales of £911.8k, make it smaller than the average company (£12.6m)
- Ipharmacy Direct Ltd
£12.6m - Industry AVG
Growth
3 year (CAGR) sales growth of 20%, show it is growing at a faster rate (7.6%)
- Ipharmacy Direct Ltd
7.6% - Industry AVG
Production
with a gross margin of 32.4%, this company has a comparable cost of product (32.4%)
- Ipharmacy Direct Ltd
32.4% - Industry AVG
Profitability
an operating margin of 5.9% make it more profitable than the average company (2.9%)
- Ipharmacy Direct Ltd
2.9% - Industry AVG
Employees
with 11 employees, this is below the industry average (75)
11 - Ipharmacy Direct Ltd
75 - Industry AVG
Pay Structure
on an average salary of £26.5k, the company has an equivalent pay structure (£26.5k)
- Ipharmacy Direct Ltd
£26.5k - Industry AVG
Efficiency
resulting in sales per employee of £82.9k, this is less efficient (£143.9k)
- Ipharmacy Direct Ltd
£143.9k - Industry AVG
Debtor Days
There is insufficient data available for this Key Performance Indicator!
- Ipharmacy Direct Ltd
- - Industry AVG
Creditor Days
its suppliers are paid after 99 days, this is slower than average (64 days)
- Ipharmacy Direct Ltd
64 days - Industry AVG
Stock Days
it holds stock equivalent to 5 days, this is less than average (34 days)
- Ipharmacy Direct Ltd
34 days - Industry AVG
Cash Balance
has cash to cover current liabilities for 66 weeks, this is more cash available to meet short term requirements (14 weeks)
66 weeks - Ipharmacy Direct Ltd
14 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 62.9%, this is a similar level of debt than the average (59.4%)
62.9% - Ipharmacy Direct Ltd
59.4% - Industry AVG
IPHARMACY DIRECT LTD financials
Ipharmacy Direct Ltd's latest turnover from November 2023 is estimated at £911.8 thousand and the company has net assets of £151.2 thousand. According to their latest financial statements, Ipharmacy Direct Ltd has 11 employees and maintains cash reserves of £326.8 thousand as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
Nov 2023 | Nov 2022 | Nov 2021 | Nov 2020 | Nov 2019 | Nov 2018 | Nov 2017 | Nov 2016 | Nov 2015 | Nov 2014 | Nov 2013 | |
---|---|---|---|---|---|---|---|---|---|---|---|
Turnover | |||||||||||
Other Income Or Grants | |||||||||||
Cost Of Sales | |||||||||||
Gross Profit | |||||||||||
Admin Expenses | |||||||||||
Operating Profit | |||||||||||
Interest Payable | |||||||||||
Interest Receivable | |||||||||||
Pre-Tax Profit | |||||||||||
Tax | |||||||||||
Profit After Tax | |||||||||||
Dividends Paid | |||||||||||
Retained Profit | |||||||||||
Employee Costs | |||||||||||
Number Of Employees | 11 | 8 | 10 | 11 | 11 | ||||||
EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
Nov 2023 | Nov 2022 | Nov 2021 | Nov 2020 | Nov 2019 | Nov 2018 | Nov 2017 | Nov 2016 | Nov 2015 | Nov 2014 | Nov 2013 | |
---|---|---|---|---|---|---|---|---|---|---|---|
Tangible Assets | 35,876 | 38,893 | 21,116 | 6,384 | 5,254 | 6,568 | 8,210 | 9,082 | 8,926 | 5,620 | 0 |
Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments & Other | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Fixed Assets | 35,876 | 38,893 | 21,116 | 6,384 | 5,254 | 6,568 | 8,210 | 9,082 | 8,926 | 5,620 | 0 |
Stock & work in progress | 8,780 | 6,580 | 5,760 | 4,560 | 0 | 0 | 3,539 | 4,099 | 4,250 | 3,350 | 0 |
Trade Debtors | 0 | 0 | 0 | 16,944 | 353,308 | 0 | 0 | 0 | 0 | 0 | 0 |
Group Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Misc Debtors | 36,339 | 31,052 | 19,614 | 22,449 | 0 | 14,317 | 16,602 | 10,562 | 0 | 0 | 0 |
Cash | 326,809 | 382,995 | 370,735 | 297,504 | 0 | 253,037 | 134,753 | 98,330 | 54,950 | 21,395 | 0 |
misc current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
total current assets | 371,928 | 420,627 | 396,109 | 341,457 | 353,308 | 267,354 | 154,894 | 112,991 | 59,200 | 24,745 | 0 |
total assets | 407,804 | 459,520 | 417,225 | 347,841 | 358,562 | 273,922 | 163,104 | 122,073 | 68,126 | 30,365 | 0 |
Bank overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Bank loan | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Trade Creditors | 168,762 | 171,201 | 77,615 | 54,544 | 325,031 | 48,927 | 40,601 | 45,629 | 66,474 | 46,776 | 0 |
Group/Directors Accounts | 20,846 | 106,706 | 200,875 | 245,323 | 0 | 156,709 | 82,187 | 24 | 0 | 0 | 0 |
other short term finances | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other current liabilities | 67,022 | 42,990 | 37,740 | 37,919 | 0 | 27,176 | 16,835 | 22,314 | 0 | 0 | 0 |
total current liabilities | 256,630 | 320,897 | 316,230 | 337,786 | 325,031 | 232,812 | 139,623 | 67,967 | 66,474 | 46,776 | 0 |
loans | 0 | 40,225 | 50,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
total long term liabilities | 0 | 40,225 | 50,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
total liabilities | 256,630 | 361,122 | 366,230 | 337,786 | 325,031 | 232,812 | 139,623 | 67,967 | 66,474 | 46,776 | 0 |
net assets | 151,174 | 98,398 | 50,995 | 10,055 | 33,531 | 41,110 | 23,481 | 54,106 | 1,652 | -16,411 | 0 |
total shareholders funds | 151,174 | 98,398 | 50,995 | 10,055 | 33,531 | 41,110 | 23,481 | 54,106 | 1,652 | -16,411 | 0 |
Nov 2023 | Nov 2022 | Nov 2021 | Nov 2020 | Nov 2019 | Nov 2018 | Nov 2017 | Nov 2016 | Nov 2015 | Nov 2014 | Nov 2013 | |
---|---|---|---|---|---|---|---|---|---|---|---|
Operating Activities | |||||||||||
Operating Profit | |||||||||||
Depreciation | 8,969 | 9,723 | 5,047 | 1,314 | 1,642 | 1,802 | 1,959 | 1,234 | |||
Amortisation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
Tax | |||||||||||
Stock | 2,200 | 820 | 1,200 | 4,560 | 0 | -3,539 | -560 | -151 | 900 | 3,350 | 0 |
Debtors | 5,287 | 11,438 | -19,779 | -313,915 | 338,991 | -2,285 | 6,040 | 10,562 | 0 | 0 | 0 |
Creditors | -2,439 | 93,586 | 23,071 | -270,487 | 276,104 | 8,326 | -5,028 | -20,845 | 19,698 | 46,776 | 0 |
Accruals and Deferred Income | 24,032 | 5,250 | -179 | 37,919 | -27,176 | 10,341 | -5,479 | 22,314 | 0 | 0 | 0 |
Deferred Taxes & Provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash flow from operations | |||||||||||
Investing Activities | |||||||||||
capital expenditure | |||||||||||
Change in Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
cash flow from investments | |||||||||||
Financing Activities | |||||||||||
Bank loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Group/Directors Accounts | -85,860 | -94,169 | -44,448 | 245,323 | -156,709 | 74,522 | 82,163 | 24 | 0 | 0 | 0 |
Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Long term loans | -40,225 | -9,775 | 50,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
share issue | |||||||||||
interest | |||||||||||
cash flow from financing | |||||||||||
cash and cash equivalents | |||||||||||
cash | -56,186 | 12,260 | 73,231 | 297,504 | -253,037 | 118,284 | 36,423 | 43,380 | 33,555 | 21,395 | 0 |
overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
change in cash | -56,186 | 12,260 | 73,231 | 297,504 | -253,037 | 118,284 | 36,423 | 43,380 | 33,555 | 21,395 | 0 |
ipharmacy direct ltd Credit Report and Business Information
Ipharmacy Direct Ltd Competitor Analysis
Perform a competitor analysis for ipharmacy direct ltd by selecting its closest rivals, whether from the WHOLESALE AND RETAIL TRADE; REPAIR OF MOTOR VEHICLES AND MOTORCYCLES sector, other small companies, companies in OL6 area or any other competitors across 12 key performance metrics.
ipharmacy direct ltd Ownership
IPHARMACY DIRECT LTD group structure
Ipharmacy Direct Ltd has no subsidiary companies.
Ultimate parent company
IPHARMACY DIRECT LTD
08314332
ipharmacy direct ltd directors
Ipharmacy Direct Ltd currently has 1 director, Mr Amjid Shakoor serving since Nov 2012.
officer | country | age | start | end | role |
---|---|---|---|---|---|
Mr Amjid Shakoor | United Kingdom | 50 years | Nov 2012 | - | Director |
P&L
November 2023turnover
911.8k
+30%
operating profit
54k
0%
gross margin
32.4%
-3.64%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
November 2023net assets
151.2k
+0.54%
total assets
407.8k
-0.11%
cash
326.8k
-0.15%
net assets
Total assets minus all liabilities
ipharmacy direct ltd company details
company number
08314332
Type
Private limited with Share Capital
industry
47730 - Dispensing chemist in specialised stores
incorporation date
November 2012
age
12
incorporated
UK
ultimate parent company
accounts
Total Exemption Full
last accounts submitted
November 2023
previous names
N/A
accountant
-
auditor
-
address
2 raynham street, ashton-under-lyne, OL6 9NU
Bank
-
Legal Advisor
-
ipharmacy direct ltd Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to ipharmacy direct ltd.
ipharmacy direct ltd Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for IPHARMACY DIRECT LTD. This can take several minutes, an email will notify you when this has completed.
ipharmacy direct ltd Companies House Filings - See Documents
date | description | view/download |
---|